Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis

Meliconi, R; Andreone, P; Fasano, L; Galli, S; Pacilli, A; Miniero, R; Fabbri, M; Solforosi, L; Bernardi, M
March 1996
Thorax;Mar1996, Vol. 51 Issue 3, p315
Academic Journal
No abstract available.


Related Articles

  • Autoantibodies in Hepatitis C Virus Infected Patients and Their Association with Hepatic Fibrosis: A Retrospective Analysis. Eltayab, F.; Abbarah, S.; Alamari, M.; AL-Masri, N.; Bzeizi, K.; Mdani, A. Al; Albenmousa, A. // Saudi Journal of Gastroenterology;2016 Supplement, Vol. 22, pS11 

    An abstract of the article "Autoantibodies in Hepatitis C Virus Infected Patients and Their Association with Hepatic Fibrosis: A Retrospective Analysis" by F. Eltayab and others is presented.

  • Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. Arase, Yasuji; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Akuta, Norio; Kobayashi, Masahiro; Kawamura, Yusuke; Yatsuji, Hiromi; Sezaki, Hitomi; Hosaka, Tetsuya; Hirakawa, Miharu; Saito, Satoshi; Ikeda, Kenji; Kumada, Hiromitsu; Saab, Sammy // World Journal of Gastroenterology;10/14/2008, Vol. 14 Issue 38, p5880 

    AIM: To investigate the cumulative development incidence and predictive factors for idiopathic pulmonary fibrosis in hepatitis C virus (HCV) positive patients. METHODS: We studied 6150 HCV infected patients who were between 40-70 years old (HCV-group). Another 2050 patients with hepatitis B...

  • Correction: Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection.  // Annals of Internal Medicine;8/20/2013, Vol. 159 Issue 4, p308 

    A correction to the article "Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection" published in the 2013 issue of the periodical is presented.

  • Hepatitis C Virus RNA Detection in Oral Lichen Planus Tissue. Nagao, Y.; Kameyama, T.; Sata, M. // American Journal of Gastroenterology;May1998, Vol. 93 Issue 5, p850 

    Presents a letter to the editor which reports on the incidence of Hepatitis C virus infection in patients with Oral Lichen Planus.

  • Reply to Marcellin et al. Re, Vincent Lo; Tate, Janet P.; Lim, Joseph K.; Fiellin, David A.; Justice, Amy C. // Clinical Infectious Diseases;Oct2014, Vol. 59 Issue 8, p1192 

    A response from the author of the article "Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus? infected, and uninfected patients" is presented.

  • Hepatitis C. Alper, Brian S.; Selius, Brian A. // Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p59 

    Presents an overview of hepatitis C. Number of people infected by hepatitis C; Etiology of hepatitis C virus; Prognosis of patient with hepatitis C virus infection.

  • Accelerated Liver Fibrosis: Two Risk Groups. McCashland, T. M.; Thompson, Jon S. // American Journal of Gastroenterology;Apr2000, Vol. 95 Issue 4, p866 

    Discusses research being done on liver fibrosis. Reference to studies published in a 1999 issue of "Hepatology"; Comparison between patients coinfected by HIV and Hepatitis C virus (HCV) and those infected with HCV only; Predictors of severe fibrosis.

  • Correlation Between Histologic Staging, Hepatitis C Virus Genotypes and Clinical Features in HCV Chronic Hepatitis: Evidence of A New Pattern.  // International Journal of Surgical Pathology;Jul2003, Vol. 11 Issue 3, p197 

    Examines the association between hepatitis C virus (HCV) subtypes and clinical and histological features of chronically infected patients. Biopsies of chronic hepatitis; Performance of HCV genotyping on frozen tissue; Assessment of the grading of necroinflammatory activity and staging of fibrosis.

  • Clinical Benefit of Therapy in Patients with Severe Fibrosis Due to Chronic Hepatitis C Virus (HCV) Infection.  // Clinical Infectious Diseases;3/15/2008, Vol. 46 Issue 6, pvi 

    The article focuses on a medical study which delved into the clinical benefit of therapy in patients with severe fibrosis, due to chronic hepatitis C virus (HCV) infection. The therapy for chronic HCV infection, combined with ribavirin and an Interferon (IFN)-Α preparation, when successful,...

  • Human Immunodeficiency Virus and Hepatitis C Virus: Which Is the Cart, and Which Is the Horse? Jenny-Avital, Elizabeth R. // Clinical Infectious Diseases;9/1/2003, Vol. 37 Issue 5, p739 

    Focuses on HIV and Hepatitis C Virus. Acceleration of Hepatitis C Virus by HIV-induced immunosuppression; Relation between the duration of Hepatitis C Virus infection and fibrosis progression rate.


Read the Article


Sign out of this library

Other Topics